Views wanted on the traditional use and safety of Moringa stenopetala as a novel food by 15 June 2019

Last updated:
5 June 2019
The Advisory Committee for Novel Food and Processes (ACNFP) has reviewed a notification under the Novel Food Regulation from a company seeking authorisation of its product in the EU. The ACNFP has completed a safety assessment of this product and is now asking for public comments on its draft opinion.

The notification is for Moringa stenopetala dried leaf powder. The product is intended to be used in a range of food categories, including dried fruits and vegetables and herbal and fruit infusions.

This notification is seeking authorisation under the traditional food process of the Novel Food Regulation. It relates to a food traditionally consumed in countries outside of the EU but not previously consumed in Europe. Further details on the notification can be found on the Commission website.

Views are requested from members of the public on the ACNFP’s draft opinion, particularly on whether there are additional considerations that the Committee should be aware of in finalising its opinion.

ACNFP’s draft opinion on Moringa stenopetala dried leaf powder.

How to comment

Comments on the draft opinion should be emailed to the ACNFP secretariat at acnfp@food.gov.uk by Saturday 15 June 2019.

All views and comments will be made available for public examination as part of the Committee’s consideration of the notification. If you would prefer your comments not to be made publicly available, please indicate this in your response.

Novel foods and the traditional food process

A novel food is a food, or food ingredient, that does not have a significant history of consumption within the European Union before 15 May 1997. Traditional foods consumed in countries outside of the EU are a subset of novel foods. They can be authorised to be placed on the market in the EU under the traditional food process. Under this process applicants submit their notification for authorisation to the European Commission. EU member states and EFSA are then asked to consider if, based on the evidence provided by the applicant seeking authorisation, they have safety concerns with the product concerned.

In the UK, assessment is undertaken by the ACNFP, an independent committee of scientists appointed by the FSA. Its views are used to inform the UK position on the notification submitted by the applicant. If concerns are raised, a further assessment is undertaken before the product is placed on the market.

Further details regarding the application process for novel foods are available on the European Commission website.